-transparent.png){kind=logo}
Cyclic nucleotide phosphodiesterase activities were examined in lymphocytes from 12 transformed human B cell lines, two T cell lines, six patients with lymphocytic leukemia, and 10 normal donors. A consistent difference bwtween cells from the normal and leukemic state was observed. The cyclic AMP phosphodiesterase activity from normal lymphocytes is inhibited greater than 80% by muM cyclic GMP while this concentration of nucleotide has little or no effect on the enzyme from transformed lymphocytic cell lines or from lymphocytic cells of leukemia patients. The reported lack of cyclic GMP phosphodiesterase in human lymphocytes from several sources is confirmed. The apparent absence of a cyclic GMP degradation mechanism and of cyclic GMP control of cyclic AMP hydrolysis may be related to defective lymphocyte growth control.
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
January 1984,
Advances in cyclic nucleotide and protein phosphorylation research,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
December 1980,
Prostaglandins and medicine,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
August 1972,
Biochimica et biophysica acta,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
January 1987,
International journal of immunopharmacology,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
March 1971,
Biochemical and biophysical research communications,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
December 1978,
Cellular immunology,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
April 1980,
Biochimica et biophysica acta,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
December 1971,
Annals of the New York Academy of Sciences,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
December 1997,
British journal of haematology,
D J Takemoto, and
W N Lee, and
S A Kaplan, and
M M Appleman
May 2004,
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
